news
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months
18 October 2011 | By GlaxoSmithKline
RTS,S* reduces the risk of malaria by half...
List view / Grid view
Search results for malaria - 173 results
news
Novartis signs on to support Malaria No More’s Power of One campaign to stride towards a future without malaria
25 April 2013 | By Novartis
"We believe that this innovative campaign will help speed malaria elimination..."
news
New malaria target identified with potential to prevent, block, and treat multiple stages of the malaria life cycle
28 November 2013 | By Novartis
Novartis scientists have discovered a new drug target for treating malaria...
news
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants
9 November 2012 | By GlaxoSmithKline
Results from ongoing Phase III clinical trial announced...
news
Sanofi-aventis and Medicines for Malaria Venture join forces to develop innovative malaria drugs
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
news
Novartis and Malaria No More help fulfill malaria treatment goal in Zambia by raising funds for three million treatments through Power of One
12 November 2014 | By Novartis
Novartis announced that, through Power of One, enough funds have been raised to deliver three million antimalarial treatments for children in Zambia...
news
WHO urges countries to “step up” the fight against malaria
2 December 2020 | By Hannah Balfour (European Pharmaceutical Review)
The WHO’s World malaria report suggests the progress in eradicating malaria has slowed due to funding shortages and that COVID-19 disruptions could result in additional deaths.
news
AstraZeneca and MMV Join Efforts in the Fight Against Malaria
28 June 2010 | By AstraZeneca
AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria...
news
Sanofi extends collaboration with Medicines for Malaria Venture
8 July 2015 | By Victoria White
Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria...
news
Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children
8 October 2013 | By GlaxoSmithKline
These latest results demonstrated that over 18 months of follow-up, RTS,S was shown to almost halve the number of malaria cases...
news
Monoclonal antibody prevents malaria in small NIH trial
12 August 2021 | By Anna Begley (European Pharmaceutical Review)
One dose of a monoclonal antibody developed at the US National Institutes of Health (NIH) prevented malaria for up to nine months.
news
Sanofi confirms its decades-long commitment to the fight against Malaria
29 November 2011 | By Sanofi
Sanofi organizes the 10th Edition of the Pan-African Conference against Malaria with representatives of 34 African Countries...
news
UNICEF signs first ever malaria vaccine supply contract with GSK
22 August 2022 | By Hannah Balfour (European Pharmaceutical Review)
Securing 18 million doses of GSK’s RTS,S malaria vaccine, UNICEF calls the contract a major breakthrough for child health.
news
Malaria control efforts can benefit from forecasting using satellites
20 February 2017 | By Niamh Marriott, Digital Editor
Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...
news
L9LS antibody safe and highly protective against malaria, finds study
5 August 2022 | By Hannah Balfour (European Pharmaceutical Review)
Phase I human challenge study shows a single subcutaneous injection of the monoclonal antibody L9LS provides at least short-term protection against malaria.
